• Pharmacists Might Be Near Front of Line for COVID-19 Vaccines, When Available
• Alcohol Use Increased Significantly During COVID-19 Stay-at-Home Orders
• Tocilizumab Shows Promise for Lessing Cytokine Storm for COVID-19 Patients
• New Guidance for Pharmacists to Administer COVID-19 Vaccines When Approved
• Pharmacists Should Expect Challenges in Increasing COVID-19 Vaccine Uptake
• Avoidance or Delay of Care Was Common Earlier in COVID-19 Pandemic
• Pharmacists Urged to Help Find Trial Participants for COVID-19 Prevention
• Remdesivir Benefits Less Clear in Patients With Moderate COVID-19 Pneumonia
• Severe Obesity Linked to COVID-19 Mortality: What Can Be Done?
• How Safe Are ACE-I, ARB Medications in COVID-19 Patients With Hypertension?
• Corticosteroids Improve COVID-19 Recovery, Now Are Recommended Therapy
• Acute Pancreatitis Appears to Be Presenting Symptom of COVID-19
• Metformin Might Protect Against High COVID-19 Mortality in Diabetes Patients
• Intermediate Doses of LMWH Appear Safe in Older COVID-19 Patients
• What Symptoms Come First in COVID-19? Study Provides Some Answers
• Percent of Americans Willing to Get COVID-19 Vaccine Drops Below Half
• Make Sure Methanol-Based Hand Sanitizers Aren’t Being Sold, Ingested
• High Liver Enzyme Levels Are Associated With Severe COVID-19 Cases
• What to Tell Recovering COVID-19 Patients About Their Recovery Time
• Sputum Testing for COVID-19 More Accurate Than Widely Used Methods
• Some COVID-19 Patients Might Present with Infection-Related Mouth Lesions
• Should COVID-19 Push Hospitals to Change Stroke Protocols for ED Staff Safety?
• Higher Viral Load Surprisingly Linked to Less Severe COVID-19 Cases
• Largest Pharmacy Chains Require Customers to Wear Masks During Pandemic
• Review: Benefits of Inhaled Steroids Outweigh COVID-19 Risks
• FDA Grants Fast Track Designation to Experimental COVID-19 Vaccines
• Watch Out for Bradycardia in COVID-19 Patients Treated With Lopinavir/Ritonavir
• Prescriptions for Hydroxychloroquine, Chloroquine Soared Earlier in Pandemic
• COVID-19’s Effect on Taste, Smell Improves in a Month for Most Patients
• ‘Happy Hypoxia’ Might Not Be Such A Mystery After All in COVID-19 Patients
• COVID-19 Changes Complicate Efforts to Assure Medication Safety
• New Information on Multisystem Condition Related to Pediatric COVID-19
• Ischemic Stroke Appears to Be More in Common in COVID-19 Vs. Influenza
• Some ART Formulations Reduce COVID-19 Risk, Hospitalization Rates
• Pregnant Women Are at Higher Risk for Serious COVID-19 Infection
• New York Study Finds That COVID-19 Is An Independent Risk Factor for Stroke
• Large Review Identifies Most Common Symptoms of COVID-19
• Gout Drug Colchicine Shows Benefits in Severe COVID-19 Treatment
• How to Avoid Airborne Infection From Patients With COVID-19
• No Return to ‘Business As Usual’ at Pharmacies Post-COVID-19
• Lack of Taste, Smell Can Aid Early Identification of Patients With COVID-19
• Researchers Investigate Whether MMR Vaccine Is Protective Against COVID-19
• Face Masks: Which One to Wear in What Clinical Situations
• Pharmacists Be Aware: Pink Eye Might Signal COVID-19 Infection
• Most Americans Worry About Drug Price Increases in Pandemic Aftermath
• Blood Cancer Drugs Show Promise in Treating Severe COVID-19
• Recovered COVID-19 Patients Are Likely to Face These Longer-Term Issues
• PPE Appears Adequate to Protect Clinicians With Frontline COVID-19 Exposure
• Pharmacy Flu Vaccination Will Require Many Special Precautions This Year
• Study Finds Masks Protect Wearer, Others Against COVID-19 Infection
• Critical Drug Shortages Can Be Better Managed by Sharing of Information
• Pharmacy Flu Vaccination Will Require Many Special Precautions This Year
• Study Finds Masks Protect Wearer, Others Against COVID-19 Infection
• Critical Drug Shortages Can Be Better Managed by Sharing of Information
• Some Americans Dangerously Drank, Gargled Cleaners as COVID-19 Prevention
• In Many Areas, Majority of COVID-19 Deaths Occurred in Long Term Care
• Drugs for Rheumatic Conditions Usually Don’t Worsen COVID-19 Course
• Indigestion Drug Famotidine Shows Promise for Helping COVID-19 Symptoms
• Literature Review Supports Physician Distancing, Masks As COVID-19 Protection
• Acute Mental Distress in Pandemic Could Up Future Psychological Disorders
• More on Use of Remdesivir to Hasten Recovery for Severe COVID-19 Patients
• Two Studies Offer Information on How COVID-19 Presents in Healthcare Workers
• Case Study Reveals Subacute Thyroiditis Linked to COVID-19 in Young Woman
• Hydroxychloroquine Study Launches for Non-Hospitalized COVID-19
• Treatments Restore Heart Function in Children With COVID-19-Realted Condition
• Pre-existing Asthma Lengthens Ventilator Time for Younger COVID-19 Patients
• Early Blood-Clotting Testing, Treatment Might Help Severe COVID-19 Patients
• Pharmacists Should Be Aware of Accuracy Issues with COVID-19 Testing
• Promising Results in Early Stages of COVID-19 Vaccine Development
• Pharmacy Infection Control Groups Raise Concerns About COVID-19 Testing
• Recognizing-Alerting Parents About Severe COVID-19 in Pediatric Patients
• Serious Gastrointestinal Symptoms Also Can Signal COVID-19 Infection
• Pharmacies Can Help Expand Testing With Relaxed Medicare Rules
• Well-Controlled T2D Glucose Levels Improves COVID-19 Outcomes
• Study Warns of 'Severe' Impact from COVID-19 on Obstetric Care
• Is Androgen Deprivation Therapy Protective Against COVID-19 in Men?
• Anti-Inflammatory Added to Remdesivir for Promising Study’s Second Phase
• Stroke Evaluations Dropped Nearly 40% During Early COVID-19 Pandemic
• Early Anticoagulant Treatment Appears to Improve Survival in Severe COVID-19
• Hyperinflammatory Shock Seen in Some Children With Current, Past COVID-19
• Why-Pharmacies-Should-Worry-About-Presymptomatic-Asymptomatic-COVID-19
• Remdesivir Shows Promise for Helping COVID-19 Patients Recover More Quickly
• What Medications Are Okay for Continued Use by Patients With COVID-19?
• Pharmacists Asked to Help Document Dermatologic COVID-19 Manifestations
• Disinfectant Risks Go Beyond Firestorm Over President's Queries
• Large Drugstore Chains Gearing Up to Offer More COVID-19 Testing
• Case Study Looks at tPA Use for COVID-19 Coagulopathy
• Hydroxychloroquine Didn’t Reduce Death, Ventilation Need in COVID-19
• Loss of Taste, Smell Could Be Early Indication of COVID-19 Infection
• Medication Alterations Might Be Necessary in COVID-19 Patients With Diabetes
• COVID-19 Infects Many Healthcare Professionals, Mostly in Work Settings
• Here Are the Best Ways to Decontaminate N95 Respirators for Reuse
• Neuropsychiatric Effects Could Go on for Years for Recovered Covid-19 Patients
• Concerns Raised About CV Effects of Hydroxychloroquine/Azithromycin
• Lower Health Literacy Plagues Some Americans Most Vulnerable to COVID-19
• HHS Authorizes Pharmacists to Order, Administer COVID-19 Tests
• CDC: Here’s How Pharmacies Can Remain Safe During COVID-19 Outbreak
• Could Immune System Boosters Make COVID-19 Less Dangerous for the Elderly?
• ASHP Pushes to Increase Supply of Drugs Critical for Patient Ventilation
• COVID-19 Drug Shortages Looming, Especially in Acute Care
• Investigational HIV/Breast Cancer Drug Promising for COVID-19 Treatment
• Despite Low Severity in Children, COVID-19 Is Risky for Some Pediatric Patients
• Alert Patients Taking Glucocorticoids That They Face Enhanced COVID-19 Risks
• No Evidence That NSAIDS, Other Drugs Are Unsafe for Coronavirus Patients
• Pharmacists Might Test for COVID-19 At Some Point; How Does It Work?
• With COVID-19, Pharmacists OKed for Expanded Practice in Some States, Seek It in Others
• Emergency Use Okayed for Hydroxychloroquine Sulfate to Treat COVID-19
• Journal Article Argues for Continued ARB Use, Despite COVID-19 Concerns
• Lopinavir Ritonavir Shows No Significant Benefit in Treating COVID-19
• Here's What Pharmacists Can Do to Protect Staff During Coronavirus Outbreak
• Hypothesis Questions Whether ACEIs, ARBs Might Worsen COVID-19 Symptoms
• Possible COVID-19 Treatment Leads to Shortages of Chronic Disease Drugs
• FDA Eases Restrictions on Use of Drugs Requiring REMS Testing
• Should Corticosteroids Be Used to Treat COVID-19 Hyperinflammation?
• UCONN Pharmacy CE: SARS-CoV-2 and COVID-19: A Primer for Pharmacists and Technicians

Hide